To assess gallbladder (GB) wall thickening and periportal tracking on CT in patients with acute pyelonephritis (APN) by each kidney involvement. Materials and Methods: A total of 117 patients diagnosed with APN by clinical examination and CT were included in this retrospective study. The patients were divided into three groups based on kidney involvement seen on CT: right APN, left APN, and bilateral APN. Two radiologists reviewed CT images in consensus for the presence of diffuse GB wall thickening and periportal tracking. The prevalence of these two manifestations was compared among the three groups. Results: The prevalence of GB wall thickening in patients with right APN (26.4%) and bilateral APN (19%) was significantly higher than in patients with left APN (0%) (p < 0.016). The prevalence of periportal tracking in patients with right APN (15.1%) and bilateral APN (26%) was higher than in patients with left APN (3%), with a significant difference between patients with bilateral APN and left APN (p < 0.016). Conclusion: GB wall thickening and periportal tracking are predominantly encountered on CT in patients with APN involving the right kidney (right and bilateral APN), and should be considered in differential diagnosis of diseases associated with GB wall thickening and periportal tracking.
INTRODUCTION
Diffuse gallbladder (GB) wall thickening is a nonspecific finding, and may be seen in a variety of pathologic conditions extrinsic to the biliary tree, which include hepatitis, heart failure and hypoalbuminemia (1) . Periportal tracking is also a nonspecific finding, and can be detected in cases of cirrhosis, hepatitis, hepatic masses, biliary obstruction, congestive heart failure, liver transplant recipients and bone marrow transplant recipients (2, 3) .
Several studies found that patients with acute pyelonephritis (APN) occasionally have diffuse GB wall thickening and periportal tracking on CT imaging (4) (5) (6) (7) . Moreover, GB wall thickening and periportal tracking were the most frequent extra-re-nal findings of APN, present in more than one-third of cases (4, 7) . Accordingly, GB wall thickening and periportal tracking should not be misdiagnosed as acute cholecystitis or hepatic disease in patients with APN (4) . However, to our knowledge, GB wall thickening and periportal tracking have not yet been discussed by kidney laterality involved by APN. On the basis of previous studies and also our own institutional experience that GB wall thickening and periportal tracking were visible predominantly in patients with APN involving the right kidney, we hypothesized that APN involving the right kidney, but not the left, may be associated with GB wall thickening and periportal tracking. Therefore, our study aimed to assess GB wall thickening and periportal tracking identified on computed tomography (CT) in patients with APN according to the involve-The excretory phase scans were obtained 5 minutes after contrast injection.
All patients received 120-150 mL of iopromide (Ultravist 300, Bayer Healthcare, Berlin, Germany) through an 18 or 20 gauge angiocatheter inserted into a forearm vein. The contrast material was injected at a rate of 3 mL/s using an automatic power injector. Scanning parameters for 4-MDCT were as follows: 4 × 2.5 mm detector collimation, 120 kVp, 130 mAs, 5 mm slice thickness, and 5 mm reconstruction interval. Parameters for 64-channel MDCT were as follows: 64 × 0.625 mm detector collimation, 120 kVp, 300 mAs, 5 mm slice thickness, and 5 mm reconstruction interval.
Imaging Analysis
CT findings positive for APN were defined as follows: lowdensity wedge-shaped areas of kidneys, poor corticomedullary differentiation, striated bands of alternating hyper-and hypoattenuation parallel to the axes of the tubules and collecting ducts, and focal or global renal enlargement (8, 9) . The images were reviewed by two radiologists (one radiologist with 14 years of experience in body imaging and a third-year radiology resident) working together and the findings were agreed upon by consensus. The readers were aware that the patients had APN.
The presence of GB wall thickening and periportal tracking was then analyzed in conjunction with the diagnosis of APN.
GB wall thickening in our study was defined as diffuse submucosal wall thickening more than 3 mm. Irregular or focal thickening was not considered to be GB wall thickening. Periportal tracking was defined as a circumferential zone of low attenuation identified around the peripheral or segmental portal venous branches.
Statistical Analysis
The patients with APN demonstrated on CT were divided into three groups according to the involvement of each kidney: right APN, left APN, and bilateral APN. Fisher's exact test was used to evaluate the differences in prevalence of GB wall thickening and periportal tracking between the three groups. Null hypotheses of no difference were rejected if p-values were less than 0.05.
Multiple comparisons were performed between two groups (right APN group vs. left APN group, bilateral APN group vs. left APN group, right APN group vs. bilateral APN group). ment of each kidney.
MATERIALS AND METHODS

Patients
This study was approved by our Institutional Review Board, and informed consent was waived because of the retrospective nature of the study. We reviewed the computerized medical records at our medical center and found a total of 1731 patients ( Fig. 1 ) and four patients with right APN (Fig. 2 ) had GB wall thickening and periportal tracking simultaneously. There were significant differences in the prevalence of GB wall thickening (p = 0.002) and periportal tracking (p = 0.026) among the three groups. The bilateral APN group had a significantly higher prevalence of GB wall thickening (p = 0.010) and periportal tracking (p = 0.012) than the left APN group. The right APN group also had a higher prevalence of GB wall thickening than Bonferroni's correction was performed for multiple comparisons, with a level of significance less than 0.016 (0.05/3). All statistical analyses used a commercially-available statistical software program (SPSS V11.0K, SPSS Inc., Chicago, IL, USA). Table 1 summarizes the prevalence of GB wall thickening and periportal tracking in the three groups. Six patients with bilateral APN It is important to note that GB wall thickening and periportal tracking could be related to abnormalities of lymphatic drainage both directly and indirectly. In a classic study in 1935, Parker (16) showed lymphatic drainage from the normal kidney. In the left APN group (p = 0.001). However, there was no significant difference in the prevalence of periportal tracking between the two groups (p = 0.144). No statistically significant differences were seen in the prevalence of GB wall thickening and periportal tracking in the right APN group and the bilateral APN group. Table 2 shows multiple comparisons of the prevalence of GB wall thickening and periportal tracking among the three groups. In APN, CT is an important imaging modality to confirm the diagnosis in clinically uncertain cases of renal infection, to identify high-risk patients, and to determine the boundary of disease in suspected complicated cases (11) (12) (13) (14) . Typical renal CT findings of APN obtained during the cortical and parenchymal nephrographic phases are wedge-shaped hypoattenuated areas of cortex and poor corticomedullary differentiation, probably corresponding to lobar or sublobar segments with poor perfusion and edema (8, 9) . Delayed CT scans obtained during the excretory phase often show striated bands of alternating hyper-and hypoattenuation parallel to the axes of the tubules and collecting ducts. However, extrarenal CT manifestations of APN, which include GB wall thickening, periportal Our study has some limitations. First, because our study was retrospective, it might have selection bias. The patients were taken from a select group of patients having APN demonstrated on CT. The sensitivity and specificity of CT in the diagnosis of acute pyelonephritis are estimated at 86.8% and 87.5%, respectively (20) . Therefore, some of the patients with APN that might not be observed on the CT images were not included in this study. Second, all images were interpreted in consensus by two radiologists without evaluation of interobserver agreement. Furthermore, because the readers were not blinded to the fact that the patients had APN when assessing the GB wall thickening and periportal tracking, there could be bias in interpretation. Third, our CT protocol was not uniform and various CT scanners were used because our study was retrospective. A final limitation of our study is that we did not assess the relationship between the severity of APN and the extrarenal manifestations.
RESULTS
DISCUSSION
The presence of diffuse GB wall thickening in cirrhotic patients is associated with clinical/laboratory variables (21) . A prospective study involving more patients is warranted to correlate the extrarenal manifestations with the severity of the illness.
In conclusion, GB wall thickening and periportal tracking are predominantly encountered on CT in patients with APN
